Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study

The prognosis of steroid-refractory acute graft-versus-host disease (aGVHD) remains poor and better treatments are urgently needed. Multipotent mesenchymal stromal cell (MSC)-based therapy emerged as a promising approach but response rates were highly variable across studies. We conducted a multicen...

Descripción completa

Detalles Bibliográficos
Autores principales: Servais, Sophie, Baron, Frédéric, Lechanteur, Chantal, Seidel, Laurence, Selleslag, Dominik, Maertens, Johan, Baudoux, Etienne, Zachee, Pierre, Van Gelder, Michel, Noens, Lucien, Kerre, Tessa, Lewalle, Philippe, Schroyens, Wilfried, Ory, Aurélie, Beguin, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945536/
https://www.ncbi.nlm.nih.gov/pubmed/29755674
http://dx.doi.org/10.18632/oncotarget.25020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945536/
https://www.ncbi.nlm.nih.gov/pubmed/29755674
http://dx.doi.org/10.18632/oncotarget.25020

Ejemplares similares